Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation.
about
Management of HBV Infection in Liver Transplantation PatientsKASL clinical practice guidelines: management of chronic hepatitis BAntibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donorsProphylaxis and treatment of hepatitis B recurrence after liver transplantation in the antiviral era.A concise update on the status of liver transplantation for hepatitis B virus: the challenges in 2002.Hepatitis B: progress in the last 15 years.Prevention of recurrent hepatitis B post-liver transplantation.Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era.Experience with lamivudine therapy for hepatitis B virus infection before and after liver transplantation, and review of the literature.Treatment of hepatitis B and C after liver transplantation. Part 1, hepatitis B.KASL Clinical Practice Guidelines: Management of chronic hepatitis B.Prevention of hepatitis B virus recurrence after liver transplantation.Hepatitis B immunoglobulin in preventing reinfection following liver transplantation.Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation.Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: a systematic review.Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation.Hepatitis B immune globulin in liver transplantation prophylaxis: an update.Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues.Multicenter review of liver transplant for hepatitis B-related liver disease: disparities in gender and ethnicity.Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin.The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients.Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors.Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: long-term results.The long-term efficacy of nucleos(t)ide analog plus a year of low-dose HBIG to prevent HBV recurrence post-liver transplantation.No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants.Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation.A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis.Hepatitis B immune globulin and HBV-related liver transplantation
P2860
Q24529103-2A039191-7CB7-477E-B1DD-1DF3BBFE060FQ26752475-151579BA-22D8-42D7-89A1-B7EE54CD4C79Q28344359-D4999568-7B93-4892-A71F-0BD141EA45E2Q33207885-85BE6CBE-8D38-40C7-AB87-9C3783DDE85FQ34499694-3AAB458F-EE5A-4DBB-9C6F-9E6BB4F7C502Q34936238-CB8423DA-D240-4D38-BD02-DE1E3A0E308CQ34936261-59E5A509-55A5-42F5-9DC1-895D8EF2EA7EQ35076630-0DBF9F8F-9305-446B-AADA-AC6C59A8C310Q35110095-C13DF224-F3C6-47FF-9852-6710DC548FC5Q36028324-8E8D8A57-5BF7-4D9B-A84D-C8F735F2A91CQ36153966-2A5FA423-63F7-4472-A1A6-0A907E88B19AQ36652077-618F7A73-D3A5-4C78-B400-1E1CD3B05754Q37432104-A7A7AC7F-5274-4B5B-8FDB-2B780796A66AQ37495757-535A2610-A9E2-4591-A70D-2F68929206B5Q37764964-6F70B8BE-65D3-4648-9775-8A22044759F8Q37982346-E59C7C8E-2C61-415C-AE60-517342EB2C66Q38006958-DDD1B3AF-9AC7-4D90-9323-69F6C99C5884Q38121508-8557EE0C-7596-4F0F-9DA4-FC06031BE09FQ38137238-180C9CD6-A13D-4DAB-8369-16B6DC573DC7Q38514411-D57B8782-1768-47D0-9592-FEAEEC9D9A34Q40611613-09182736-4A7B-441A-A0E4-DD67DE224CBFQ42369605-A53D68D4-BE4C-4DEF-896F-D1678961B016Q43666871-0DC4DF6E-827C-4AFC-8509-24F51D67A386Q44217548-B4FE9D4B-7DF7-4282-ADC9-BCFBEE12CE1CQ44425133-7AF9E8A8-8065-4326-AF9F-D163BE17410CQ45250862-89CC24EF-3D17-4529-89E3-171BF0D6658EQ45421748-811A42C3-8525-4651-A360-CB737BAEEE21Q46313699-3E366B45-C915-4CD7-B302-AC736AE864ECQ54188543-A57A0E06-7304-43E9-A649-1E6B3211FD80
P2860
Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Lamivudine after hepatitis B i ...... e after liver transplantation.
@ast
Lamivudine after hepatitis B i ...... e after liver transplantation.
@en
type
label
Lamivudine after hepatitis B i ...... e after liver transplantation.
@ast
Lamivudine after hepatitis B i ...... e after liver transplantation.
@en
prefLabel
Lamivudine after hepatitis B i ...... e after liver transplantation.
@ast
Lamivudine after hepatitis B i ...... e after liver transplantation.
@en
P2093
P356
P1476
Lamivudine after hepatitis B i ...... e after liver transplantation.
@en
P2093
C A Bonham
D A Geller
M E de Vera
S F Dodson
P304
P356
10.1053/JLTS.2000.6446
P577
2000-07-01T00:00:00Z